EyeBio
eyebiotech.comLocations
London, UK · New York, NY, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series A
founded in
2021
Eyebiotech is a vision treatment company that develops products to preserve, repair, and improve eyesight. The firm guards against sight-threatening eye disorders and developed the first anti-vascular endothelial growth factor medication for patients with age-related macular degeneration, allowing those with eye ailments to regain their eyesight.
Something looks off?Open jobs at EyeBio
On-site & Remote
Job function
Seniority
Salary